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Temporal	lobe	epilepsy	(TLE)	is	known	as	the	most	common	form	of	epilepsy	in	adults	and	as	
the	type	most	resistant	to	treatment.	Neuroprotective	treatments	are	considered	as	a	promising	
therapy	for	preventing	and	treating	TLE.	We	investigated	the	possible	neuroprotective	effect	
of	vitamin	E	in	an	intrahippocampal	kainate	model	of	TLE	in	rats.	Kainate	injection	caused	
a	higher	incidence	rate	of	seizures,	and	vitamin	E	pretreatment	significantly	attenuated	this	
index.	 Intrahippocampal	 kainate	 also	 led	 to	 elevation	 of	 the	 malondialdehyde	 and	 nitrite/
nitrate	levels	and	lowered	superoxide	dismutase	(SOD)	activity,	while	vitamin	E	significantly	
restored	MDA and	SOD	indices.	In	addition,	intrahippocampal	kainate	induced	a	significant	
degeneration	of	neurons	in	the	CA1,	CA3,	and	hilar	regions	of	the	hippocampus;	vitamin	E	
considerably	attenuated	these	changes.	Timm	staining	data	demonstrated	mossy	fiber	sprouting	
(MFS)	in	the	dentate	gyrus	of	kainate-lesioned	rats,	and	vitamin	E	significantly	lowered	the	
MFS	intensity.	Our	data	suggest	that	vitamin	E	pretreatment	is	capable	of	attenuating	seizures	
and	inhibiting	hippocampal	neuronal	loss	and	MFS	in	the	kainate-induced	model	of	TLE.	A	
part	of	the	beneficial	vitamin	E	effects	is	due	to	its	potential	to	mitigate	oxidative	stress.
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INTRODUCTION
Epilepsy	 is	 a	widespread	chronic	brain	disorder	with	
recurrent	 seizures	 due	 to	 enhanced	 and	 synchronized	
activity	 of	 cerebral	 neurons	 [1].	 Temporal	 lobe	
epilepsy	 (TLE)	 is	 a	 prevalent	 form	 of	 epilepsy	 in	
adults,	usually	accompanied	by	hippocampal	sclerosis,	
neurodegeneration,	 and	 extense	 reorganization	 of	
hippocampal	 circuits	 [2].	 Subsequent	 development	
of	 chronic	 epilepsy,	 characterized	 by	 spontaneous	
recurrent	 seizures,	 is	 observed	 [3].	 In	 about	 40%	 of	
patients	 with	 TLE,	 seizures	 are	 refractory	 to	 current	
medicines	 [1].	 Although	 existing	 medications	 can	
symptomatically	 suppress	 seizures,	 there	 is	 little	
evidence	 that	 existing	 antiepileptic	 drugs	 could	
effectively	correct	the	underlying	abnormal	processes	
leading	 to	 epilepsy	 or	 alter	 its	 development	 [4,	 5].	
Thus,	novel	treatment	approaches	are	strongly	required	
to	prevent	or	even	reverse	 the	cellular	and	molecular	
mechanisms	 of	 epileptogenesis	 [6].	 Neuroprotective	
strategies	 are	 increasingly	 considered	 as	 a	promising	
therapy	 for	 preventing	 and	 treating	 TLE	 [3].	 A	
well-characterized	 animal	 model	 of	 TLE	 is	 based	
on	 intrahippocampal	 injections	 of	 the	 excitotoxic	
glutamate	analog	kainate	in	rodents.
The	 vitamin	 E	 family,	 including	 tocotrienols	 and	
tocopherols,	 is	 constituted	 by	 compounds	 crucially	
essential	for	living	cells;	these	compounds	are	known	
as	 one	 of	 the	 most	 effective	 antioxidants	 found	 in	
biological	 systems	 [7,	8].	Vitamin	E	 is	known	as	 an	
essential	 nutrient	 for	 animals	 and	 humans	 and	 as	 a	
potent	antioxidant	effectively	reducing	the	level	of	free	
radicals	[8].	Since	excitotoxic	stimulation	in	epilepsy	
induces	 excessive	 production	 of	 reactive	 oxygen	
species	(ROSs)	leading	to	oxidative	stress	[9],	vitamin	
E	can	act	 as	a	chain-breaking	antioxidant	protecting	
the	 cell	 membranes	 against	 oxidative	 damage	 [10].	
In	animals,	vitamin	E	can	inhibit	seizures	induced	by	
ferrous	 chloride,	 hyperbaric	 oxygen,	 and	 penicillin,	
where	ROS	production	may	play	a	very	important	role	
in	 the	development	of	seizures	 [11-13].	This	vitamin	
decreases	the	frequency	of	penicillin-induced	epileptic	
manifestations	 [11].	 In	 addition,	 vitamin	 E	 exerts	 a	
protective	 effect	 against	 pentylenetetrazol-induced	
toxicity	by	 inhibiting	production	of	 free	 radicals	and	
by	 supporting	 the	 antioxidant	 redox	 system	 [14].	
Vitamin	E	was	also	shown	 to	 reduce	kainate-induced	
neuronal	damage	in	the	hippocampus	[15].	
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Unti l 	 now, 	 there 	 is 	 no	 evidence	 on	 the	
neuroprotective	 effect	 of	 vitamin	 E	 in	 the	 kainate-
induced	 model	 of	 TLE.	 Therefore,	 we	 decided	
to	 investigate	 whether	 vitamin	 E	 ameliorates	
neurodegeneration,	mossy	fiber	sprouting	(MFS),	and	
oxidative	 stress	under	conditions	of	kainate-induced	
TLE	in	rats.
METHODS
All	experiments	were	performed	on	adult	male	Wistar	
rats	 (280-320	g;	n	 =	 48)	 (Pasteur’s	 Institute,	Tehran,	
Iran).	The	animals	were	housed	three	to	four	per	cage	
in	a	 temperature-controlled	colony	room	under	12/12	
light/dark	 cycle	 with	 food	 and	 water	 available	 ad 
libitum.	
Experimental Procedure. Rats	 were	 randomly	
divided	 into	 four	 equal-size	 groups,	 sham-operated	
(Sh),	vitamin	E-treated	and	sham-operated	(Sh	+	v.E),	
kainate	 (K),	and	kainate-injected	+	vitamin	E-treated	
(K	+	v.E).	For	 intrahippocampal	 injections,	 rats	were	
anesthetized	 with	 chloral	 hydrate	 (350	 mg/kg)	 and	
placed	into	the	stereotaxic	frame	(Stoelting	Co.,	USA)	
with	the	incisor	bar	set	at	3.3	mm	below	the	interaural	
line.	The	dorsal	surface	of	the	skull	was	exposed,	and	
a	burr	hole	was	drilled	in	the	skull	using	the	following	
stereotaxic	coordinates	[16]:	anteroposterior	(AP),	4.3	
mm	caudal	to	the	bregma;	4.2	mm	lateral	to	the	midline	
(right	 side),	 and	 4.0-4.2	 mm	 ventral	 to	 the	 surface	
of	 the	 skull.	A	5-ml	microsyringe	 filled	with	normal	
saline	 containing	 0.8	 mg/ml	 of	 kainate	 was	 placed	
over	 the	burr	hole,	and	kainate	solution	was	 injected	
at	 a	 rate	 of	 1	 ml/min.	 Kainic	 acid	 (Sigma-Aldrich,	
USA)	was	dissolved	in	cold	normal	saline	just	prior	to	
surgery.	The	Sh	group	received	an	equivalent	volume	
of	normal	 saline	at	 the	same	stereotaxic	coordinates.	
The	microsyringe	was	slowly	withdrawn	after	5	min,	
and	the	scalp	wound	was	sutured.	The	Sh	+	v.E	group	
received	vitamin	E	(alpha	tocopherol;	Sigma-Aldrich,	
USA)	 perorally	 using	 a	 gavage	 needle	 at	 a	 dose	 of	 
200	mg/kg	 ∙ day	starting	1	week	before	 surgery;	 the	
last	treatment	was	realized	1	h	before	surgery.	Vitamin	
E	was	diluted	in	propylene	glycol	(Merck,	Germany).	
The	 dose	 of	 vitamin	E	was	 chosen	 according	 to	 the	
data	 of	 previous	 reports	 on	 its	 antiepileptic	 activity	
[17,	18]	and	our	pilot	study.	
Behavioral Assessment of Seizures. All	 animals	
were	 assessed	 for	 seizure	 activity	 during	 the	 first	 
24	 h	 and	 at	 the	 5th	week	 post-surgery,	 4	 h	 per	 day	
for	5	consecutive	days	according	to	the	Racine’s	point	
classification.	 Zero	 corresponded	 to	 no	 reaction;	
1,	 stereotypic	 mounting,	 eye	 blinking,	 and/or	 mild	
facial	clonus;	2,	head	nodding	and/or	multiple	 facial	
clonus;	3,	myoclonic	jerks	in	the	forelimbs;	4,	clonic	
convulsions	 in	 the	 forelimbs	 with	 rearing,	 and	 5,	
generalized	 clonic	 convulsions	 and	 loss	 of	 balance	
[19].	
Assessment of Oxidative Stress Markers 
Measurement of the Hippocampal Malondialdehyde 
(MDA) Concentration. The	 rats	 were	 anesthetized	
with	diethyl	 ether	 and	decapitated.	Their	hippocampi	
were	 isolated,	 blotted	 dry,	 weighed,	 and	 prepared	
as	 a	 5%	 tissue	 homogenate	 in	 ice-cold	 0.9%	 saline	
solution.	After	 centrifugation	 (1,000g,	 4°C,	 10	min),	
the	supernatant	was	aliquoted	and	stored	at	–70°C	until	
assayed.	The	concentration	of	MDA	(used	as	a	marker	
of	 lipid	 peroxidation)	 was	 calculated	 by	 measuring	
thiobarbituric	 acid-reactive	 substances	 (TBARSs)	 in	
the	 supernatant	as	described	previously	 [20].	Briefly,	
trichloroacetic	acid	and	a	TBARS	reagent	were	added	
to	aliquots	of	the	supernatant,	which	were	subsequently	
mixed	and	incubated	at	90°C	for	80	min.	After	cooling	
on	 ice,	 the	 samples	 were	 centrifuged	 at	 1,000g	 for	
10	 min,	 and	 the	 absorbance	 of	 the	 supernatant	 was	
measured	spectrophotometrically	at	532	nm.	The	results	
of	 TBARS	 measurements	 were	 expressed	 as	 MDA	
equivalents,	using	tetraethoxypropane	as	the	standard.	
Assay of  the  Hippocampal  Ni tr i te /Ni trate 
Concentration. Supernatant	 nitrite/nitrate	 content	
was	 assayed	 by	 the	 Griess	 method	 as	 described	
before	 [21].	The	NO	compound	 is	characterized	by	a	
short	 half-life	 and	 is	 rapidly	 converted	 to	 the	 stable	
end	 products	 nitrate	 and	 nitrite.	 In	 this	 assay,	 color	
development	with	 the	Griess	 reagent	 (sulfanilamide	
and	N-naphthyl	ethylenediamine)	in	an	acidic	medium	
was	assessed.	The	absorbance	was	measured	using	a	
spectrophotometer	at	540	nm.
Measurement  o f  Hippocampal  Superox ide 
Dismutase ( SOD) Activity. Activity	 of	 SOD	 was	
measured	 as	 previously	 reported	 [21].	 Briefly,	 the	
supernatant	was	incubated	with	xanthine	and	xanthine	
oxidase	in	potassium	phosphate	buffer	(pH	7.8,	37°C)	
for	 40	 min,	 and	 then	 nitro	 blue	 tetrazolium	 (NBT)	
was	added.	Thereafter,	blue	 formazan	was	monitored	
spectrophotometrically	 at	 550	 nm.	 The	 amount	 of	
protein	that	inhibited	NBT	reduction	to	50%	maximum	
was	defined	as	one	nitrite	unit	(NU)	of	SOD	activity.	
Protein Assay.  The	 protein	 content	 of	 the	
supernatant	was	measured	 by	 the	 Bradford	method,	
using	bovine	serum	albumin	(Sigma	Chemical,	USA)	
as	the	standard	[22].	
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Histological Studies. Four	or	 five	animals	of	each	
group	were	randomly	used	for	histological	assessment.	
The	 rats	were	 deeply	 anesthetized	with	 a	 high	 dose	
of	 ketamine	 (150	 mg/kg)	 and	 perfused	 through	 the	
ascending	 aorta	 with	 50	 ml	 of	 heparinized	 normal	
saline	followed	by	100	ml	of	a	sulfide	solution	(1.2%	
Na
2
S	and	1.0%	NaH
2
PO
4
)	and	then	with	100-150	ml	of	
a	 fixative	 solution	 containing	 4%	paraformaldehyde	
in	 0.1	M	 phosphate	 buffer	 (PB,	 pH	 7.4).	 Following	
perfusion,	 the	 brains	 were	 removed	 from	 the	 skull;	
hippocampal	blocks	were	prepared	 and	 immersed	 in	
30%	sucrose	in	PB	at	4°C	for	2-3	days.	Then,	40-mm-
thick	 sections	 were	 cut	 on	 a	 freezing	 microtome	
(Leica,	Germany)	 and	 collected	 in	0.1	M	PB.	Every	
second	 section	 was	 Nissl-stained	 with	 0.1%	 cresyl	
violet	(Sigma,	USA),	and	alternate	sections	were	used	
for	Timm	staining.	In	Nissl-stained	sections,	neuronal	
loss	was	quantified	in	the	CA1,	CA3,	and	hilar	regions	
of	the	hippocampus	in	at	least	three	sections	at	a	level	
range	 between	 3.6	 and	 –4.3	 mm	 from	 the	 bregma	
using	 an	 image	 capturing	 and	 analysis	 system	 (Bel	
Engineering,	Italy).	The	process	was	repeated	at	least	
two	times	for	each	section;	its	average	was	calculated	
and	taken	as	the	final	value.	Counting	was	done	blind	
to	the	treatments	received.	
To	visualize	MFS	in	the	inner	molecular	layer	of	the	
dentate	gyrus	(DG)	that	accompanies	epileptogenesis,	
we	employed	a	modified	Timm	histological	procedure	
to	 label	 zinc-containing	 axons	 of	 the	 granule	 cells	
[23].	 The	 slices	 were	 subsequently	 immersed	 in	
100%	alcohol	for	5	min,	in	70%	alcohol	for	5	min,	in	
distilled	water	for	10	min,	and	then	stayed	in	the	dark	
under	continuous	agitation	 for	60	min	 in	 the	Timm’s	
working	solution	of	the	following	composition:	60	ml	
of	50%	gum	Arabic,	10	ml	of	2	M	sodium	citrate	buffer	
(pH	3.7),	30	ml	of	5.6%	hydroquinone,	and	0.5	ml	of	
17%	silver	nitrate	solution.	The	staining	process	was	
terminated	with	2%	sodium	acetate,	and	the	unreacted	
silver	ions	were	removed	with	5%	sodium	thiosulfate.	
The	 sections	 were	 counterstained	 with	 0.1%	 cresyl	
violet,	dehydrated,	and	coverslipped.	The	assessment	
of	MFS	(as	a	Timm	index)	was	obtained	from	the	value	
of	the	area	of	Timm	granules	divided	by	the	length	of	
the	DG	[24].	The	Timm	index	for	each	animal	was	the	
mean	of	 three	 sections.	All	 procedures	 and	 analyses	
were	done	blind	to	the	treatments.	
Statistical Analysis. All	 statistical	 analyses	were	
performed	 using	 SigmaStat	 software	 (version	 3.5).	
Numerical	values	were	expressed	as	means	±	s.e.m.	To	
compare	the	experimental	groups,	non-behavioral	data	
were	 analyzed	 using	 one-way	ANOVA	 followed	 by	
the	Tukey’s	post hoc	 test.	Seizure-related	behavioral	
data	were	analyzed	using	the	non-parametric	Kruskal–
Wallis	 test.	 The	 percentage	 of	 rats	 with	 seizures	
was	examined	by	 the	χ2	 test.	 In	all	analyses,	 the	null	
hypothesis	was	rejected	at	a	P	level	below	0.05.	
RESULTS
Behavioral Assessment of Seizure Activity.	 Sham	
and	Sh	+	v.E	groups	showed	no	signs	of	seizure	activity	
during	the	first	24	h	post-surgery	interval	and/or	after	
4	weeks.	 In	 contrast,	 all	 rats	 (100%)	 in	 the	K	 group	
exhibited	high	scores	of	seizures	during	the	first	24	h	
post-surgery,	and	58.3%	of	them	had	seizures	at	the	5th	
week.	At	the	same	time,	rats	injected	with	kainate	and	
pretreated	with	 vitamin	 E	 (K	 +	 v.E	 group)	 exhibited	
noticeably	 lower	 seizure	 activity	 as	 compared	 to	 the	
K	group.	In	this	respect,	only	41.6	and	16.7%	of	such	
rats	 demonstrated	 seizures	 during	 the	 first	 24	 h	 and	
at	 the	5th	week	post-surgery,	and	 this	difference	was	
statistically	 significant	vs	 the	K	group	 (P <	0.05	and	 
P <	0.01,	respectively;	Table	1).
Oxidative Stress Markers. Vitamin	E	pretreatment	
of	the	Sh	+	v.E	group	caused	no	significant	change	in	
the	hippocampal	levels	of	MDA	and	nitrite/nitrate	and	
activity	of	SOD	as	compared	to	the	Sh	group.	In	con-
trast,	 the	K	group	 showed	 a	 significant	 elevation	 of	
the	MDA	(P <	0.01)	and	nitrite/nitrate	(P <	0.05)	con-
TABLE 1. Numbers of Animals with Seizure Activity at Different Post-Surgery Intervals 
Кількість тварин, у яких була виявлена судомна активність у межах різних післяопераційних інтервалів
Experimental	groups
Numbers	of	rats	with	seizures
within	an	initial	24-h	interval at	the	5th	week
Sham	(Sh) 0/12 (0%) 0/12 (0%)
Sham+Vitamin	E	(Sh	+	v.E) 0/12 (0%) 0/12 (0%)
Kainate	(K) 12/12 (100%) 7/12 (58.3%)
Kainate	+	Vitamin	E	(K	+	v.E) 5/12 (41.6%)* 2/12 (16.7%)**
Footnotes.	Normalized	numbers,	%,	are	shown	in	parentheses.	*P	<	0.05	and	**P <	0.01	as	compared	to	the	K	group.	
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in the CA1,	CA3,	and	hilar	regions	of	the	hippocampus	
were	counted	and	compared	among	groups	(Fig.	4).	Our	
results	showed	that	vitamin	E	pretreatment	of	sham	ani-
mals	(Sh	+	v.E)	produced	no	significant	shift	in	this	re-
gard.	In	contrast,	intrahippocampal	injections	of	kainate	
induced	dramatic	statistically	significant	degeneration	
of	 neurons	 and	 reduction	of	 their	 density	 in	 the	CA1 
(P <	0.05),	CA3	 (P <	0.005),	and	hilar	 (P <	0.01)	 re-
gions	of	 the	hippocampus	vs	 the	Sh	group.	 In	 this	 re-
gard,	neurodegeneration	in	the	hippocampus	was	typi- 
fied	by	an	apparent	cell	 loss	 in	 the	dentate	gyrus	and	
hilus	 and	 considerable	 thinning	 of	 cell	 layers	 in	 the	
CA1 and CA3	regions	and	dentate	gyrus	of	rats	of	the	K	
group.	This	led	to	increase	in	the	granule	cell	dispersion	
(GCD)	and	displacement	of	 their	 layer;	 the	 latter	was	
2	to	3	times	broader	in	the	upper	border.	Furthermore,	
vitamin	E	pretreatment	of	kainate-injected	rats	signifi-
cantly	attenuated	the	respective	changes	in	the	CA1	(P 
<	0.05),	CA3	(P <	0.01),	and	hilar	(P <	0.05)	regions	as	
compared	to	the	K	group.	These	data	suggest	that	vita-
min	E	pretreatment	can	protect	and	rescue	the	neurons	
of	hippocampal	regions	against	kainate-induced	neuro-
toxicity.
Timm Histochemistry. Mossy	fibers	 from	granule	
cells	 in	 the	 dentate	 gyrus	 undergo	 reorganization	 of	
their	 terminal	projections	 in	both	epilepsy	 in	humans	
and	 animal	models	 of	 epilepsy	 [24].	Timm	 staining	
is	 a	well-accepted	method	 for	 visualization	 of	 zinc-
containing	neuronal	elements.	Our	observations	con-
cerning	zinc	histochemistry	in	the	hippocampus	are	in	
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F i g. 2. Nitrite/nitrate	 content	 in	 the	 hippocampal	 homogenate.	 
*P	<	0.05	in	comparison	with	the	sham	group.	Other	designations	
are	similar	to	those	in	Fig.	1.
Р и с. 2. Вміст	нітритів/нітратів	у	гіпокампальному	гомогенаті.
Sh K K + v.ESh + v.E
*
F i g. 3.	Superoxide	dismutase	(SOD)	activity	(vertical	scale,	U/mg	
protein)	in	the	hippocampal	homogenate.	*P	<	0.05	in	comparison	
with	 the	 sham	 group;	 # P <	 0.05	 in	 comparison	 with	 the	 kainate	
group.	Other	designations	are	similar	to	those	in	Figs.	1	and	2.
Р и с. 3.	Активність	 супероксиддисмутази	 (вертикальна	шка- 
ла,	од./мг	протеїну)	в	гіпокампальному	гомогенаті.	
tents	and	a	significant	 reduction	of	 the	SOD	activity	 
(P <	0.05).	The	pretreatment	of	the	K	group	with	vita-
min	E	(K	+	v.E)	significantly	attenuated	the	increased	
MDA	concentration	(P <	0.05)	and	enhanced	the	activ-
ity	of	SOD	(P <	0.05)	but	did	not	significantly	change	
the	nitrite	content.	At	 the	same	 time,	 the	 level	of	ni-
trite/nitrate	 was	 slightly	 and	 non-significantly	 low-
er	 in	 the	K	+	v.E	group	as	compared	 to	 the	K	group	 
(Figs.	1-3).
Cytoarchitecture of the Hippocampus (Nissl Stain-
ing). In	this	study,	the	numbers	of	neurons	per	unit	area	
F i g. 1.	 Mean	 malondiadehyde	 (MDA)	 concentration	 (vertical	
scale,	nmol/mg	protein)	 in	 the	hippocampal	homogenate	obtained	
from	 animals	 of	 different	 groups	 (shown	 below).	 **P	 <	 0.01	 in	
comparison	with	the	sham	group;	#P <	0.05	in	comparison	with	the	
kainate	group	(n	=	6-7).
Р и с. 1. Середня	 концентрація	 малонового	 альдегіду	 (верти-
кальна	шкала	–	нмоль/мг	протеїну)	у	гіпокампальному	гомоге-
наті,	отриманому	від	тварин	різних	груп.
0 Sh K K + v.ESh + v.E
**
#
6
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agreement	with	 the	 literature	data	 [25].	 In	our	study,	
kainate-induced	MFS	was	demonstrated	by	the	Timm	
method	at	 the	5th	week	post-surgery	(Fig.	5).	Synap-
tic	terminals	of	mossy	fibers	were	selectively	labeled	
due	 to	 their	 high	 zinc	 content.	 In	 the	 Sh	 group,	 lit-
tle	 sprouting	was	present	 in	 the	DG	molecular	 layer.	
In	contrast,	Timm	staining	showed	MFS	that	extended	
into	the	dentate	supragranular	layer	in	the	K	group.	In	
the	vitamin	E-pretreated	group	(K	+	v.E),	supragranu-
lar	MFS	was	less	intense	and	more	dispersed,	 though	
it	was	 still	 denser	 than	 in	 the	 Sh	 group.	We	 further	
compared	 the	average	width	and	Timm	staining	den-
sity	(characterized	by	the	Timm	index)	between	the	K	
and	K	+	v.E-pretreated	groups	and	found	that	vitamin	
E	pretreatment	 significantly	 reduced	 the	MFS	width	
and	 staining	density	 (P <	0.01).	These	data	 indicate	
that	vitamin	E	is	able	to	restrain	kainate-induced	MFS.	
DISCUSSION
Temporal	 lobe	 epilepsy	 is	 a	 chronic	 and	 intractable	
neurological	disorder	with	recurrent	seizures;	it	results	
from	the	development	of	abnormal	recurrent	excitatory	
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F i g. 4.	 Neurodegenerative	 changes	 in	 kainate-injected	 rats.	A)	 
Numbers	 of	 Nissl-stained	 neurons	 in	 different	 areas	 of	 the	
hippocampus	 (designations	 are	 similar	 to	 those	 in	 Fig.	 1).	 B)	
photomicrographs	 (1-4)	 of	 coronal	 sections	 through	 the	 dentate	
region	from	animals	of	four		groups:	sham-operated	(Sh),	vitamin	
T-treated	and	sham-operated	 (Sh	+	v.E),	kainate	 (K),	 and	vitamin	
E-pretreated	 kainate	 (K	 +	 v.E),	 respectively.	 Severe	 reduction	 in	
the	number	of	neurons	in	the	hilar	region	(solid	filled	arrows)	and	
neuronal	 dispersion	 in	 the	 upper	 blade	 (dotted	 open	 arrow)	were	
observed	 in	 the	 K	 group,	 but	 no	 such	 changes	 were	 prominent	
in	 the	K	+	 v.E	 group.	 *P <	0.05,	 **P <	0.01,	 and	 ***P <	0.005	
in	 comparison	 with	 the	 Sh	 group;	 #P <	 0.05	 and	 ##P <	 0.01	 in	
comparison	with	the	K	group	(n =	4-5).
Р и с. 4.	Нейродегенеративні	зміни	у	щурів,	ін’єкованих	каїна-
том.
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F i g. 5.	 Mossy	 fiber	 sprouting	 (MFS)	 in	 kainate-injected	 rats.	
A)	 Timm	 index	 in	 different	 groups	 as	 an	 indicator	 of	 MFS;	 B)	
photomicrographs	 through	 the	 dentate	 region,	 which	 show	 MFS	
revealed	by	Timm	staining	in	different	groups	(1-4).	*P <	0.05	and	
***P <	 0.005	 in	 comparison	with	 the	 sham	 group;	 ##P <	 0.01	 in	
comparison	with	the	kainate	group	(n =	4-5).
Р и с. 5.	Спраутинг	моховитих	волокон	у	щурів	після	ін’єкцій	
каїнату.
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and/or	 inhibitory	 circuits.	 Recurrent	 excitation	 and	
the	 development	 of	 seizures	 are	 also	 associated	with	
aberrant	MFS	 in	 the	hippocampus	 [26].	 Intracerebral	
injections	 of	 kainate	 into	 the	 CA3	 region	 of	 the	
hippocampus	 cause	 initiation	 or	 intensification	 of	
epileptic	seizures.	These	seizures	are	followed	by	cell	
loss	similar	to	that	observed	in	patients	suffering	from	
TLE	 [27].	 Considering	 this,	 kainate-induced	 brain	
damage	 has	 been	 routinely	 used	 for	 modeling	 TLE	
and	 excitotoxic	 neurodegenerative	 disorders	 [28].	
Accumulating	 evidence	 indicates	 that	 hippocampal	
oxidative	 stress	 is	 noticeably	 involved	 in	 kainate-
induced	 neurotoxicity	 [29].	 Kainate	 in	 general	 acts	
through	 three	classes	of	 ionotropic	receptors,	namely	
NMDA	(N-methyl-D-aspartate),	AMPA	(alpha-amino-
3-hydroxy-5-methyl-4-isoxazole	 propionic	 acid),	
and	 kainate	 receptors.	 Among	 different	 ionotropic	
glutamate	 receptors,	 kainic	 acid	 receptors	 (KARs),	
containing	 the	 GluR6	 subunit,	 are	 important	 in	
synaptic	transmission,	as	well	as	 in	the	epileptogenic	
effects	of	kainate	[30].	Therefore,	these	receptors	are	
expected	 to	 be	 overexpressed	 in	 the	 CA3 region in 
intrahippocampal	 kainate-induced	 TLE.	 This	 factor	
promotes	 the	 development	 of	 seizures	 and	 ensues	
pathology,	 including	 degeneration	 of	 hippocampal	
neurons	 and	 an	 aberrant	MFS	 in	 the	 inner	molecular	
layer	of	the	DG	[24].	
In	our	study,	a	massive	neuronal	loss	was	found	in	
the CA1,	CA3,	and	hilar	regions	in	the	K	animal	group.	
Typical	aberrant	mossy	fibers	invading	into	the	gran-
ule	cell	 layer	and	granule	cell-inner	molecular	 layer	
in	the	hippocampus	of	these	rats	were	noticed;	this	is	
consistent	with	observations	in	previous	studies	[24].	
Kainate	 injection	 into	 the	hippocampus	 led	 to	dege- 
neration	of	CA3	pyramidal	neurons	and	dentate	hilar	
cells.	The	granule	cell	axons	(known	as	mossy	fibers),	
originating	from	the	DG,	lose	their	postsynaptic	target	
cells	and	sprout	into	the	inner	molecular	layer.	These	
pathological	changes	cause	the	formation	of	function-
al	 recurrent	excitatory	circuits	between	granule	cells	
that	may	contribute	to	recurrent	seizures	in	our	study	
[24,	31].
Following	kainate	injection,	intensification	of	oxid- 
ative	stress	occurs	 [32],	and	 the	development	of	 sei-
zures	is	also	associated	with	such	stressogenic	condi-
tions	[33].	On	the	other	hand,	a	deficiency	of	 the	an-
tioxidant redox systems can exacerbate the etiology 
of	 epilepsy	 [34].	 Increased	 lipid	peroxidation	 in	 the	
brain	was	 reported	 in	pentylenetetrazol-induced	epi-
lepsy	in	rats	[35].	Moreover,	seizure	activity	is	related	
to	increased	levels	of	free	radicals	and	reduced	activ-
ity	of	the	antioxidant	defense	mechanisms	[17].	Thus,	
epileptiform	states	with	 seizures	are	associated	with	
an	imbalance	between	oxidant	and	antioxidant	defense	
mechanisms.	
Vitamin	E	 as	 a	 lipophilic	 antioxidant	 protects	 the	
membranes	 from	being	oxidatively	damaged	by	 free	
radicals	and	attenuates	lipid	peroxidation	in	the	brain	
[36].	Although	 the	 role	 of	 inflammation	 in	 the	 used	
model	of	TLE	was	not	evaluated	in	our	present	study,	
vitamin	 E	may	 also	 exerts	 certain	 protective	 effect	
against	 seizures	 in	 kainate-injected	 rats	 through	 its	
anti-inflammatory	 activity	 [37].	 However,	 concepts	
on	 the	 role	 of	 anti-inflammatory	 agents	 in	 progres-
sion	and	prevention	of	epilepsy	are	controversial	[38,	
39].	The	kainate-induced	seizure	rat	model	is	accom-
panied	by	 inflammation	with	 increased	production	of	
certain	prostaglandins,	such	as	prostaglandin	E2;	this	
follows	an	enhancement	in	the	mRNA	levels	of	cyclo-
oxygenase	2	and	prostaglandin	E2	synthase	(PGEs)	in	
the	brain	tissue.	Anti-inflammatory	agents	can	reduce	
the	severity	of	 the	corresponding	conditions	 [40].	 In	
parallel	with	 this	 fact,	 it	was	 shown	 that	kainate-in-
duced	excitotoxicity	through	induction	of	matrix	me-
talloproteinases	leads	to	selective	neuronal	death	and	
neuroinflammation	 in	 the	hippocampus;	 inhibitors	of	
such	enzymes	can	attenuate	the	ensuing	neuronal	dam-
age,	and	 this	could	be	 therapeutically	 relevant	 in	 the	
related	neurological	disorders	[41].	On	the	other	hand,	
it	was	mentioned	above	 that	vitamin	E	 is	capable	of	
manifesting	anti-inflammatory	properties	[42];	this	as-
pect	needs	further	investigation.
The	neuroprotective	and	antiapoptotic	potential	of	
vitamin	 E	 reduces	 the	 detrimental	 action	 of	 neuro-
toxins	and/or	excitotoxic	agents	on	neurons	 [43,	44].	
In	our	study,	due	 to	 the	neuroprotective	effect	of	vit- 
amin	E,	we	observed	 lower	degrees	of	neuronal	 loss	
and	MFS	in	the	K	+	v.E	group	than	those	in	the	K	one.	
Previous	 studies	 demonstrated	 that	 vitamin	 E	 could	
ameliorate	pentylenetetrazol-induced	seizure	activity	
by	 inhibiting	production	of	 free	radicals	and	support-
ing	the	antioxidant	redox	system	[45].	In	addition,	the	
neuroprotective	anti-oxidative	stress	effect	of	vitamin	
E	with	respect	 to	hippocampal	neurons	was	shown	in	
the	cell	culture	[46].	In	our	study,	pretreatment	with	vi-
tamin	E	in	the	kainate-injected	group	attenuated	oxid- 
ative	stress	burden,	as	was	evident	from	a	significant-
ly	 lower	 level	of	MDA	and	higher	activity	of	SOD	in	
the	hippocampal	 tissue,	and	 this	was	associated	with	
less	severe	seizure	activity.	Results	of	our	study	clearly	
suggest	that	vitamin	E	counteracts	kainate-induced	epi-
lepsy	(at	least	partly)	by	functioning	as	an	anti-oxidant.	
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Therefore,	pretreatment	with	vitamin	E	attenuates	
seizure	 activity	 and	 inhibits	 hippocampal	 neuronal	
loss	and	MFS	in	the	kainate-induced	rat	model	of	TLE,	
and	 its	beneficial	effect	 is	partly	due	 to	 its	ability	 to	
mitigate	oxidative	stress.
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НЕЙРОПРОТЕКТОРНИЙ	ЕФЕКТ	ВІТАМІНУ	E	В	УМО-
ВАХ	КАЇНАТІНДУКОВАНОЇ		МОДЕЛІ	«СКРОНЕВОЇ»	
ЕПІЛЕПСІЇ	У	ЩУРІВ	
1	Нейрофізіологічний	дослідницький	центр	Університету	
„Шахед”,	Тегеран	(Іран).
Р	е	з	ю	м	е
«Скронева»	епілепсія	(СЕ)	–	найпоширеніша	форма	епілеп-
сії	у	дорослих,	причому	найбільш	резистентна	до	лікування.	
Як	перспективний	напрямок	у	профілактиці	та	лікуванні	СЕ	
розглядаються	підходи,	засновані	на	нейропротекції.	Ми	до-
сліджували	можливий	нейропротекторний	ефект	вітаміну	Е	
на	„каїнатній”	моделі	СЕ	у	щурів	(інтрагіпокампальне	вве-
дення	каїнату).	Такі	 ін’єкції	 зумовлювали	підвищену	ймо-
вірність	прояву	судом,	а	попереднє	курсове	введення	вітамі-
ну	Е	істотно	знижувало	відповідний	індекс.	Ін’єкції	каїнату	
також	призводили	до	зростання	рівнів	малонового	альдегіду	
та	нітритів/нітратів	і	падіння	активності	супероксиддисму-
тази;	під	впливом	вітаміну	Е	відповідні	значення	нормалізу-
валися.	До	того	ж,	інтрагіпокампальні	введення	каїнату	ви-
кликали	істотну	дегенерацію	нейронів	у	зонах		CA1	та	CA3 
і	хілусі	гіпокампа,	а	вітамін	Е	значно	обмежував	ці	зміни.	
Результати	 забарвлення	 за	 Тіммом	 продемонстрували	 на-
явність	феномену	спраутинга	моховитих	волокон	у	зубчас-
тій	звивині	щурів	після		введення	каїнату;	вітамін	Е	істотно	
зменшував	 інтенсивність	даного	процесу.	Наші	результати	
дозволяють	нам	вважати,	що	попередня	дія	вітаміну	Е	спри-
яє	зменшенню	інтенсивності	судом,	знижує	загибель	нейро-
нів	у	гіпокампі	та	обмежує	спраутинг	в	умовах	каїнатної	мо-
делі	СЕ.	Позитивний	ефект	вітаміну	Е	частково	зумовлений	
його	здатністю	послаблювати	оксидативний	стрес.		
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